Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)TWB-103 for Treating Lower Limb Ulcers on Patients With DM
- First Posted Date
- 2018-08-09
- Last Posted Date
- 2023-07-12
- Lead Sponsor
- Transwell Biotech Co., Ltd.
- Target Recruit Count
- 10
- Registration Number
- NCT03624023
- Locations
- 🇨🇳
National Taiwan University Hospital, Taipei, Taiwan
🇨🇳Tri-Service General Hospital, Taipei, Taiwan
TWB-103 for Adult Patients With Split-Thickness Skin Graft Donor Site Wounds
Phase 1
Completed
- Conditions
- Donor Site Complication
- Interventions
- Drug: TWB-103 GroupDrug: Placebo Group
- First Posted Date
- 2016-04-14
- Last Posted Date
- 2023-07-28
- Lead Sponsor
- Transwell Biotech Co., Ltd.
- Target Recruit Count
- 48
- Registration Number
- NCT02737748
- Locations
- 🇯🇵
Nippon Medical School, Tokyo, Japan
🇯🇵Tokyo Medical University, Tokyo, Japan
🇨🇳Tri-Service General Hospital, Taipei, Taiwan
News
No news found